SEC Comment Letter for Lite Strategy, Inc. (LITS) (CIK 0001262104) (LITS) — Nov 26, 2012
Lite Strategy, Inc. (LITS) (CIK 0001262104)
Date: Nov. 26, 2012 · CIK: 0001262104 · Accession: 0000000000-12-063786
AI Filing Summary & Sentiment
Reasoning
Letter
November 26 , 2012 Via E -mail Daniel P. Gold President and Chief Executive Officer MEI Pharma, Inc. 11975 El Camino Real, Suite 101 San Diego, CA 92130
Re: MEI Pharma, Inc. Preliminary Information Statement on Schedule 14C Filed November 9, 2012 File No. 000 -50484
Dear Mr. Gold :
We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Jeffrey P. Riedler
Show Raw Text
November 26 , 2012 Via E -mail Daniel P. Gold President and Chief Executive Officer MEI Pharma, Inc. 11975 El Camino Real, Suite 101 San Diego, CA 92130 Re: MEI Pharma, Inc. Preliminary Information Statement on Schedule 14C Filed November 9, 2012 File No. 000 -50484 Dear Mr. Gold : We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Jeffrey P. Riedler Jeffrey P. Riedler Assistant Director cc: Via E -mail Finnbarr D. Murphy Morgan, Lewis & Bockius LLP